|
100
|
253
|
3w5tA |
Crystal structure of complexes of vitamin d receptor ligand binding domain with lithocholic acid derivatives |
|
99
|
253
|
3w0jA |
Crystal structure of rat vdr ligand binding domain in complex with novel nonsecosteroidal ligands |
|
96
|
251
|
3vt8A |
Crystal structures of rat vdr-lbd with w282r mutation |
|
95
|
251
|
3vt5A |
Crystal structures of rat vdr-lbd with r270l mutation |
|
103
|
271
|
3vn2A |
Crystal structure of ppargamma complexed with telmisartan |
|
95
|
251
|
3vt7A |
Crystal structures of rat vdr-lbd with w282r mutation |
|
101
|
251
|
3vjtA |
Vitamin d receptor complex with a carborane compound |
|
98
|
251
|
3vt4A |
Crystal structures of rat vdr-lbd with r270l mutation |
|
93
|
251
|
3vt9A |
Crystal structures of rat vdr-lbd with w282r mutation |
|
97
|
250
|
3vrwA |
Vdr ligand binding domain in complex with 22s-butyl-2-methylidene-26,27-dimethyl-19,24-dinor-1alpha,25-dihydroxyvitamin d3 |
|
95
|
274
|
3vjiA |
Human ppar gamma ligand binding domain in complex with jkpl53 |
|
100
|
251
|
3vtcA |
Crystal structure of rat vitamin d receptor bound to a partial agonist 26-adamantyl-23-yne-19-norvitammin d adtk3 |
|
103
|
274
|
3vspA |
Human ppar gamma ligand binding domain in complex with a gamma selective agonist mekt28 |
|
99
|
252
|
3vjsA |
Vitamin d receptor complex with a carborane compound |
|
106
|
260
|
3vhvA |
Mineralocorticoid receptor ligand-binding domain with non-steroidal antagonist |
|
100
|
272
|
3vsoA |
Human ppar gamma ligand binding domain in complex with a gamma selective agonist mekt21 |
|
98
|
251
|
3vt6A |
Crystal structure of rat vdr-lbd with 2-substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin d3 |
|
99
|
251
|
3vruA |
Vdr ligand binding domain in complex with 2-methylidene-19,24-dinor-1alpha,25-dihydroxy vitamind3 |
|
96
|
274
|
3vjhA |
Human ppar gamma ligand binding domain in complex with jkpl35 |
|
98
|
251
|
3vtbA |
Crystal structure of rat vitamin d receptor bound to a partial agonist 25-adamantyl-23-yne-19-norvitammin d adtk1 |
|
99
|
250
|
3vrvA |
Vdr ligand binding domain in complex with 2-methylidene-26,27-dimethyl-19,24-dinor-1alpha,25-dihydroxyvitamin d3 |
|
99
|
255
|
3vhuA |
Mineralocorticoid receptor ligand-binding domain with spironolactone |
|
103
|
261
|
3vt3A |
Crystal structures of rat vdr-lbd with r270l mutation |
|
94
|
251
|
3vtdA |
Crystal structure of rat vitamin d receptor bound to a partial agonist 26-adamantyl-23-yne-19-norvitammin d adtk4 |
|
93
|
249
|
3vrtA |
Vdr ligand binding domain in complex with 2-mehylidene-19,25,26,27-tetranor-1alpha,24-dihydroxyvitamind3 |
|
102
|
267
|
3vi8A |
Human ppar alpha ligand binding domain in complex with a synthetic agonist aphm13 |
|
89
|
242
|
3v3qA |
Crystal structure of human nur77 ligand-binding domain in complex with ethyl 2-[2,3,4 trimethoxy-6(1-octanoyl)phenyl]acetate |
|
98
|
249
|
3v49A |
Structure of ar lbd with activator peptide and sarm inhibitor 1 |
|
104
|
271
|
3v9yA |
Crystal structure of the ppargamma-lbd complexed with a cercosporamide derivative modulator |
|
93
|
249
|
3v4aA |
Structure of ar lbd with activator peptide and sarm inhibitor 2 |
|
102
|
271
|
3v9tA |
Crystal structure of the ppargamma-lbd complexed with a cercosporamide derivative modulator |
|
104
|
271
|
3v9vA |
Crystal structure of the ppargamma-lbd complexed with a cercosporamide derivative modulator |
|
87
|
238
|
3v3eA |
Crystal structure of the human nur77 ligand-binding domain |
|
94
|
269
|
3u9qA |
Ligand binding domain of ppargamma complexed with decanoic acid and pgc-1a peptide |
|
87
|
244
|
3uuaA |
Crystal structure of hera-lbd (y537s) in complex with bisphenol-af |
|
93
|
242
|
3up3A |
Nuclear receptor daf-12 from hookworm ancylostoma ceylanicum in complex with (25s)-cholestenoic acid |
|
79
|
232
|
3uvvB |
Crystal structure of the ligand binding domains of the thyroid receptor:retinoid x receptor complexed with 3,3',5 triiodo-l-thyronine and 9-cis retinoic acid |
|
76
|
240
|
3uucA |
Crystal structure of hera-lbd (wt) in complex with bisphenol-c |
|
88
|
244
|
3uuaB |
Crystal structure of hera-lbd (y537s) in complex with bisphenol-af |
|
89
|
259
|
3uvvA |
Crystal structure of the ligand binding domains of the thyroid receptor:retinoid x receptor complexed with 3,3',5 triiodo-l-thyronine and 9-cis retinoic acid |
|
86
|
245
|
3uu7B |
Crystal structure of hera-lbd (y537s) in complex with bisphenol-a |
|
89
|
244
|
3uu7A |
Crystal structure of hera-lbd (y537s) in complex with bisphenol-a |
|
91
|
247
|
3uudB |
Crystal structure of hera-lbd (y537s) in complex with estradiol |
|
90
|
245
|
3uudA |
Crystal structure of hera-lbd (y537s) in complex with estradiol |
|
84
|
240
|
3tx7B |
Crystal structure of lrh-1/beta-catenin complex |
|
98
|
277
|
3ty0A |
Structure of ppargamma ligand binding domain in complex with (r)-5-(3-((3-(6-methoxybenzo[d]isoxazol-3-yl)-2-oxo-2,3-dihydro-1h-benzo[d]imidazol-1-yl)methyl)phenyl)-5-methyloxazolidine-2,4-dione |
|
104
|
275
|
3tkmA |
Crystal structure ppar delta binding gw0742 |
|
102
|
268
|
3t03A |
Crystal structure of ppar gamma ligand binding domain in complex with a novel partial agonist gq-16 |
|
97
|
270
|
3sz1A |
Human ppar gamma ligand binding domain in complex with luteolin and myristic acid |
|
101
|
273
|
3sp6A |
Structural basis for iloprost as a dual pparalpha/delta agonist |
